Co-trimoxazole for HIV-exposed uninfected infants
Main Authors: | Ceri Evans, Andrew J Prendergast |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-05-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X1730147X |
Similar Items
-
HIV-exposed uninfected infants in Zimbabwe: insights into health outcomes in the pre-antiretroviral therapy era
by: Ceri eEvans, et al.
Published: (2016-06-01) -
Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial
by: Brodie Daniels, PhD, et al.
Published: (2019-12-01) -
Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial
by: Shahin Lockman, MD, et al.
Published: (2017-05-01) -
The Immune System of HIV-Exposed Uninfected Infants
by: Bahaa Abu Raya, et al.
Published: (2016-09-01) -
The effect of daily co-trimoxazole prophylaxis on natural development of antibody-mediated immunity against P. falciparum malaria infection in HIV-exposed uninfected Malawian children.
by: Herbert Longwe, et al.
Published: (2015-01-01)